Leukoencephalopathy is a structural alteration of cerebral white matter in which myelin suffers the most damage. Toxic leukoencephalopathy may be caused by exposure to a wide variety of agents ...

One complication is toxic leukoencephalopathy, which is due to a direct toxic effect of chemotherapeutic agents on the central nervous system white matter. Autopsies of four cases of toxic ...

We attribute her reversible posterior leukoencephalopathy to DMSO rather than to renal insufficiency because she was not uremic when she developed the leukoencephalopathy, and even as she became ...

Additionally, this report indicates that frequently used chemotherapeutic agents such as vincristine and actinomycin-D might lead to reversible posterior leukoencephalopathy syndrome and awareness ...

Of 13 patients rechallenged with intrathecal and/or high-dose MTX, 12 did not experience recurrence of neurotoxicity. Leukoencephalopathy was found in 73 (20.6%) of 355 asymptomatic patients and in ...

What Is Progressive Multifocal Leukoencephalopathy? Progressive multifocal leukoencephalopathy (PML) is a rare and serious infection that attacks part of your brain. You can get it when your body ...

They'll also ask you to let them know if you notice issues like: Eye pain A fever or chills A headache that doesn’t go away PML (progressive multifocal leukoencephalopathy), a rare but serious ...

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system caused by lytic infection of oligodendrocytes by pathogenic strains of the JC ...

This page lists all known medications that could potentially lead to 'Leukoencephalopathy' as a side effect. It's important to note that mild side effects are quite common with medications.

concerns have arisen over its association with a rare but potentially fatal brain infection called progressive multifocal ...

More information: Clinical and neuro radiographic features of fentanyl inhalation-induced Leukoencephalopathy, BMJ Case Reports (2024). DOI: 10.1136/bcr-2023-258395 Journal information: BMJ Case ...

The global progressive multifocal leukoencephalopathy (PML) treatment market is projected to experience stable growth over the next decade, reaching a value of USD 1,773.97 million by 2033, growing at ...